Annual Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
| Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
| Net Income / (Loss) Continuing Operations |
|
5.67 |
5.22 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
| Total Pre-Tax Income |
|
5.69 |
2.63 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-10 |
1.74 |
1.84 |
| Total Revenue |
|
22 |
22 |
23 |
24 |
24 |
24 |
24 |
28 |
30 |
11 |
| Net Interest Income / (Expense) |
|
-3.02 |
-3.46 |
-3.97 |
-3.39 |
-4.64 |
-4.98 |
-5.06 |
0.31 |
0.21 |
-19 |
| Total Interest Income |
|
0.01 |
0.00 |
0.03 |
0.75 |
0.00 |
0.04 |
0.00 |
0.31 |
0.21 |
0.02 |
| Total Interest Expense |
|
3.03 |
3.46 |
3.99 |
4.14 |
4.64 |
5.02 |
5.06 |
0.00 |
0.00 |
19 |
| Total Non-Interest Income |
|
25 |
25 |
27 |
28 |
29 |
29 |
29 |
28 |
30 |
29 |
| Other Service Charges |
|
0.89 |
0.96 |
1.05 |
1.05 |
1.05 |
1.02 |
0.99 |
-0.39 |
0.30 |
0.32 |
| Other Non-Interest Income |
|
24 |
24 |
26 |
27 |
28 |
28 |
28 |
28 |
29 |
29 |
| Total Non-Interest Expense |
|
16 |
17 |
30 |
18 |
20 |
20 |
21 |
21 |
22 |
21 |
| Property & Liability Insurance Claims |
|
4.33 |
4.16 |
4.87 |
4.79 |
5.46 |
5.60 |
5.79 |
5.57 |
5.99 |
5.49 |
| Other Operating Expenses |
|
3.76 |
4.15 |
16 |
3.79 |
3.62 |
3.73 |
4.55 |
4.76 |
4.94 |
4.81 |
| Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
| Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
| Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
| Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
| Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
Annual Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
2022 |
2023 |
2024 |
| Net Change in Cash & Equivalents |
9.20 |
-7.44 |
-0.25 |
| Net Cash From Operating Activities |
60 |
61 |
59 |
| Net Cash From Continuing Operating Activities |
60 |
61 |
59 |
| Net Income / (Loss) Continuing Operations |
22 |
7.71 |
-3.18 |
| Consolidated Net Income / (Loss) |
22 |
7.71 |
-3.18 |
| Provision For Loan Losses |
0.00 |
0.00 |
11 |
| Depreciation Expense |
32 |
40 |
43 |
| Amortization Expense |
0.85 |
13 |
0.93 |
| Non-Cash Adjustments to Reconcile Net Income |
6.01 |
4.82 |
8.17 |
| Changes in Operating Assets and Liabilities, net |
-0.94 |
-3.39 |
-0.81 |
| Net Cash From Investing Activities |
-114 |
-114 |
-93 |
| Net Cash From Continuing Investing Activities |
-113 |
-114 |
-92 |
| Purchase of Property, Leasehold Improvements and Equipment |
-10 |
-19 |
-25 |
| Purchase of Investment Securities |
-106 |
-101 |
-75 |
| Sale and/or Maturity of Investments |
3.00 |
6.19 |
7.42 |
| Other Investing Activities, net |
0.67 |
- |
0.22 |
| Net Cash From Financing Activities |
63 |
45 |
34 |
| Net Cash From Continuing Financing Activities |
63 |
45 |
34 |
| Issuance of Debt |
150 |
50 |
162 |
| Issuance of Common Equity |
21 |
44 |
7.49 |
| Repayment of Debt |
-63 |
-0.13 |
-83 |
| Payment of Dividends |
-44 |
-48 |
-52 |
| Other Financing Activities, Net |
-0.39 |
-1.19 |
-1.01 |
| Cash Interest Paid |
11 |
18 |
23 |
Quarterly Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
| Net Change in Cash & Equivalents |
|
0.98 |
8.73 |
-7.44 |
-0.95 |
1.26 |
-0.30 |
0.31 |
-4.21 |
2.10 |
1.55 |
| Net Cash From Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
| Net Cash From Continuing Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
| Net Income / (Loss) Continuing Operations |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
| Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
| Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
| Amortization Expense |
|
0.21 |
0.23 |
12 |
0.24 |
0.05 |
0.19 |
0.22 |
0.17 |
0.25 |
0.29 |
| Non-Cash Adjustments to Reconcile Net Income |
|
1.63 |
1.81 |
1.67 |
0.22 |
1.78 |
1.16 |
1.67 |
2.81 |
1.81 |
1.87 |
| Changes in Operating Assets and Liabilities, net |
|
-0.16 |
-0.18 |
-3.13 |
0.42 |
1.19 |
-1.87 |
-3.17 |
2.38 |
-0.90 |
0.87 |
| Net Cash From Investing Activities |
|
-22 |
-58 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.49 |
| Net Cash From Continuing Investing Activities |
|
-22 |
-57 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.43 |
| Purchase of Property, Leasehold Improvements and Equipment |
|
-3.05 |
-3.68 |
-4.14 |
-3.75 |
-3.58 |
-7.52 |
-5.11 |
-7.19 |
-7.19 |
-5.16 |
| Purchase of Investment Securities |
|
-20 |
-55 |
-25 |
-17 |
-52 |
-6.90 |
-34 |
-24 |
-8.91 |
-8.42 |
| Sale and/or Maturity of Investments |
|
0.75 |
0.75 |
0.75 |
3.78 |
0.79 |
0.87 |
0.87 |
0.75 |
1.72 |
4.09 |
| Other Investing Activities, net |
|
- |
- |
- |
- |
- |
- |
0.03 |
0.05 |
0.08 |
0.06 |
| Net Cash From Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
| Net Cash From Continuing Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
| Issuance of Debt |
|
19 |
105 |
12 |
3.00 |
33 |
2.00 |
39 |
20 |
16 |
87 |
| Repayment of Debt |
|
-0.03 |
-63 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-4.79 |
- |
-78 |
| Payment of Dividends |
|
-11 |
-11 |
-12 |
-12 |
-12 |
-12 |
-13 |
-13 |
-13 |
-13 |
| Other Financing Activities, Net |
|
-0.05 |
-0.21 |
-0.10 |
-1.01 |
-0.04 |
-0.05 |
-0.61 |
-0.06 |
-0.29 |
-0.05 |
| Cash Interest Paid |
|
2.61 |
3.21 |
4.06 |
4.16 |
2.17 |
7.34 |
4.79 |
5.91 |
6.23 |
6.14 |
Annual Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
2022 |
2023 |
2024 |
| Total Assets |
876 |
945 |
993 |
| Cash and Due from Banks |
11 |
3.49 |
4.38 |
| Restricted Cash |
0.84 |
1.14 |
0.00 |
| Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
| Premises and Equipment, Net |
778 |
849 |
903 |
| Other Assets |
87 |
91 |
85 |
| Total Liabilities & Shareholders' Equity |
876 |
945 |
993 |
| Total Liabilities |
380 |
432 |
517 |
| Other Short-Term Payables |
11 |
12 |
14 |
| Long-Term Debt |
353 |
403 |
486 |
| Other Long-Term Liabilities |
15 |
17 |
16 |
| Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
497 |
513 |
476 |
| Total Preferred & Common Equity |
497 |
513 |
476 |
| Preferred Stock |
0.00 |
0.00 |
0.00 |
| Total Common Equity |
497 |
513 |
476 |
| Common Stock |
625 |
688 |
705 |
| Retained Earnings |
-151 |
-192 |
-246 |
| Accumulated Other Comprehensive Income / (Loss) |
23 |
16 |
18 |
Quarterly Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
| Total Assets |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
| Cash and Due from Banks |
|
2.66 |
3.67 |
2.63 |
3.89 |
3.81 |
0.73 |
2.84 |
| Restricted Cash |
|
0.68 |
0.96 |
1.05 |
1.05 |
1.14 |
0.00 |
0.00 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Premises and Equipment, Net |
|
730 |
797 |
805 |
852 |
880 |
899 |
903 |
| Other Assets |
|
79 |
85 |
92 |
98 |
98 |
84 |
76 |
| Total Liabilities & Shareholders' Equity |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
| Total Liabilities |
|
333 |
392 |
395 |
433 |
471 |
485 |
505 |
| Other Short-Term Payables |
|
8.14 |
10 |
11 |
15 |
12 |
12 |
14 |
| Long-Term Debt |
|
311 |
365 |
368 |
401 |
442 |
458 |
474 |
| Other Long-Term Liabilities |
|
15 |
16 |
16 |
16 |
17 |
16 |
16 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
| Total Preferred & Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
| Preferred Stock |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
| Common Stock |
|
602 |
649 |
657 |
677 |
691 |
700 |
702 |
| Retained Earnings |
|
-145 |
-170 |
-175 |
-184 |
-201 |
-224 |
-235 |
| Accumulated Other Comprehensive Income / (Loss) |
|
21 |
16 |
23 |
29 |
21 |
21 |
10 |
Annual Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
| Metric |
2022 |
2023 |
2024 |
| Growth Metrics |
- |
- |
- |
| Revenue Growth |
7.21% |
11.64% |
-3.40% |
| EBITDA Growth |
2.99% |
9.06% |
-32.75% |
| EBIT Growth |
-1.61% |
-63.64% |
-139.66% |
| NOPAT Growth |
-1.80% |
-64.97% |
-128.87% |
| Net Income Growth |
-2.10% |
-64.97% |
-141.24% |
| EPS Growth |
-6.90% |
-75.31% |
-215.00% |
| Operating Cash Flow Growth |
6.98% |
1.83% |
-4.08% |
| Free Cash Flow Firm Growth |
-58.75% |
41.05% |
19.25% |
| Invested Capital Growth |
16.77% |
7.85% |
4.95% |
| Revenue Q/Q Growth |
1.69% |
2.41% |
-12.70% |
| EBITDA Q/Q Growth |
-0.31% |
1.86% |
-25.01% |
| EBIT Q/Q Growth |
-2.99% |
-9.01% |
-113.96% |
| NOPAT Q/Q Growth |
9.37% |
24.64% |
-605.32% |
| Net Income Q/Q Growth |
-3.82% |
-8.00% |
-613.23% |
| EPS Q/Q Growth |
-6.90% |
-4.76% |
-130.00% |
| Operating Cash Flow Q/Q Growth |
0.69% |
-1.79% |
2.39% |
| Free Cash Flow Firm Q/Q Growth |
-100.50% |
53.93% |
-71.98% |
| Invested Capital Q/Q Growth |
7.67% |
-0.76% |
1.16% |
| Profitability Metrics |
- |
- |
- |
| EBITDA Margin |
64.34% |
62.86% |
43.76% |
| EBIT Margin |
25.69% |
8.37% |
-3.43% |
| Profit (Net Income) Margin |
25.64% |
8.05% |
-3.43% |
| Tax Burden Percent |
99.81% |
96.18% |
100.00% |
| Interest Burden Percent |
100.00% |
100.00% |
100.00% |
| Effective Tax Rate |
0.19% |
3.82% |
0.00% |
| Return on Invested Capital (ROIC) |
2.79% |
0.87% |
-0.24% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
2.79% |
0.87% |
-0.45% |
| Return on Net Nonoperating Assets (RNNOA) |
1.80% |
0.65% |
-0.41% |
| Return on Equity (ROE) |
4.59% |
1.53% |
-0.64% |
| Cash Return on Invested Capital (CROIC) |
-12.68% |
-6.68% |
-5.07% |
| Operating Return on Assets (OROA) |
2.71% |
0.88% |
-0.33% |
| Return on Assets (ROA) |
2.70% |
0.85% |
-0.33% |
| Return on Common Equity (ROCE) |
4.59% |
1.53% |
-0.64% |
| Return on Equity Simple (ROE_SIMPLE) |
4.43% |
1.50% |
-0.67% |
| Net Operating Profit after Tax (NOPAT) |
22 |
7.71 |
-2.23 |
| NOPAT Margin |
25.64% |
8.05% |
-2.40% |
| Net Nonoperating Expense Percent (NNEP) |
0.00% |
0.00% |
0.21% |
| SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
74.31% |
91.63% |
91.56% |
| Earnings before Interest and Taxes (EBIT) |
22 |
8.02 |
-3.18 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
55 |
60 |
41 |
| Valuation Ratios |
- |
- |
- |
| Price to Book Value (P/BV) |
1.59 |
1.30 |
1.14 |
| Price to Tangible Book Value (P/TBV) |
1.59 |
1.30 |
1.14 |
| Price to Revenue (P/Rev) |
9.18 |
6.96 |
5.86 |
| Price to Earnings (P/E) |
35.82 |
86.48 |
0.00 |
| Dividend Yield |
5.66% |
7.38% |
9.60% |
| Earnings Yield |
2.79% |
1.16% |
0.00% |
| Enterprise Value to Invested Capital (EV/IC) |
1.33 |
1.16 |
1.06 |
| Enterprise Value to Revenue (EV/Rev) |
13.15 |
11.12 |
11.06 |
| Enterprise Value to EBITDA (EV/EBITDA) |
20.44 |
17.69 |
25.27 |
| Enterprise Value to EBIT (EV/EBIT) |
51.20 |
132.88 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
51.30 |
138.15 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
18.74 |
17.36 |
17.39 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
0.00 |
| Leverage & Solvency |
- |
- |
- |
| Debt to Equity |
0.71 |
0.79 |
1.02 |
| Long-Term Debt to Equity |
0.71 |
0.79 |
1.02 |
| Financial Leverage |
0.65 |
0.75 |
0.90 |
| Leverage Ratio |
1.70 |
1.80 |
1.96 |
| Compound Leverage Factor |
1.70 |
1.80 |
1.96 |
| Debt to Total Capital |
41.54% |
44.00% |
50.52% |
| Short-Term Debt to Total Capital |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
41.54% |
44.00% |
50.52% |
| Preferred Equity to Total Capital |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
58.46% |
56.00% |
49.48% |
| Debt to EBITDA |
6.39 |
6.69 |
11.99 |
| Net Debt to EBITDA |
6.17 |
6.62 |
11.88 |
| Long-Term Debt to EBITDA |
6.39 |
6.69 |
11.99 |
| Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
| Net Debt to NOPAT |
15.48 |
51.68 |
-216.27 |
| Long-Term Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
| Noncontrolling Interest Sharing Ratio |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
- |
- |
- |
| Cash Flow Metrics |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
-100 |
-59 |
-48 |
| Operating Cash Flow to CapEx |
580.96% |
323.39% |
238.93% |
| Free Cash Flow to Firm to Interest Expense |
-8.43 |
-3.32 |
-2.01 |
| Operating Cash Flow to Interest Expense |
5.08 |
3.45 |
2.48 |
| Operating Cash Flow Less CapEx to Interest Expense |
4.20 |
2.38 |
1.44 |
| Efficiency Ratios |
- |
- |
- |
| Asset Turnover |
0.11 |
0.11 |
0.10 |
| Fixed Asset Turnover |
0.12 |
0.12 |
0.11 |
| Capital & Investment Metrics |
- |
- |
- |
| Invested Capital |
850 |
917 |
962 |
| Invested Capital Turnover |
0.11 |
0.11 |
0.10 |
| Increase / (Decrease) in Invested Capital |
122 |
67 |
45 |
| Enterprise Value (EV) |
1,130 |
1,066 |
1,024 |
| Market Capitalization |
789 |
667 |
543 |
| Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
| Tangible Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
| Total Capital |
850 |
917 |
962 |
| Total Debt |
353 |
403 |
486 |
| Total Long-Term Debt |
353 |
403 |
486 |
| Net Debt |
341 |
399 |
482 |
| Capital Expenditures (CapEx) |
10 |
19 |
25 |
| Net Nonoperating Expense (NNE) |
0.00 |
0.00 |
0.95 |
| Net Nonoperating Obligations (NNO) |
353 |
403 |
486 |
| Total Depreciation and Amortization (D&A) |
33 |
52 |
44 |
| Earnings Adjustments |
- |
- |
- |
| Adjusted Basic Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
| Adjusted Weighted Average Basic Shares Outstanding |
23.63M |
25.20M |
26.53M |
| Adjusted Diluted Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
| Adjusted Weighted Average Diluted Shares Outstanding |
23.63M |
25.20M |
26.53M |
| Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
26.02M |
27.68M |
28.34M |
| Normalized Net Operating Profit after Tax (NOPAT) |
22 |
7.81 |
-2.14 |
| Normalized NOPAT Margin |
25.64% |
8.15% |
-2.31% |
| Pre Tax Income Margin |
25.69% |
8.37% |
-3.43% |
| Debt Service Ratios |
- |
- |
- |
| EBIT to Interest Expense |
1.86 |
0.45 |
-0.13 |
| NOPAT to Interest Expense |
1.85 |
0.43 |
-0.09 |
| EBIT Less CapEx to Interest Expense |
0.98 |
-0.62 |
-1.17 |
| NOPAT Less CapEx to Interest Expense |
0.98 |
-0.63 |
-1.13 |
| Payout Ratios |
- |
- |
- |
| Dividend Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
| Augmented Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
Quarterly Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
| Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
6.44% |
6.98% |
11.28% |
14.38% |
10.61% |
10.33% |
4.58% |
13.94% |
23.85% |
-55.80% |
| EBITDA Growth |
|
3.67% |
-1.22% |
3.88% |
15.92% |
8.40% |
7.96% |
-0.36% |
-59.49% |
27.22% |
-95.40% |
| EBIT Growth |
|
5.46% |
-11.45% |
-225.06% |
18.34% |
-33.00% |
-15.10% |
153.22% |
-167.01% |
109.62% |
-332.97% |
| NOPAT Growth |
|
-30.31% |
272.56% |
-159.16% |
17.45% |
-36.65% |
69.51% |
176.02% |
-147.27% |
122.51% |
-58.86% |
| Net Income Growth |
|
5.96% |
-14.31% |
-225.31% |
17.78% |
-38.45% |
-12.81% |
152.95% |
-258.54% |
-49.91% |
-59.89% |
| EPS Growth |
|
5.00% |
-25.00% |
-252.38% |
14.29% |
-47.62% |
-5.56% |
134.38% |
-275.00% |
-63.64% |
-76.47% |
| Operating Cash Flow Growth |
|
15.85% |
2.77% |
-11.83% |
10.31% |
15.41% |
-7.26% |
-0.43% |
0.32% |
-21.85% |
9.60% |
| Free Cash Flow Firm Growth |
|
47.30% |
-40.95% |
-459.26% |
-134.76% |
-102.95% |
47.89% |
26.61% |
16.77% |
85.16% |
29.99% |
| Invested Capital Growth |
|
9.74% |
16.77% |
16.04% |
14.22% |
17.01% |
7.85% |
10.98% |
9.38% |
2.97% |
4.95% |
| Revenue Q/Q Growth |
|
2.05% |
0.44% |
6.07% |
5.21% |
-1.32% |
0.18% |
0.54% |
14.63% |
7.27% |
-64.25% |
| EBITDA Q/Q Growth |
|
0.18% |
-0.74% |
2.85% |
13.34% |
-6.31% |
-1.14% |
-6.36% |
-53.92% |
194.20% |
-96.42% |
| EBIT Q/Q Growth |
|
1.68% |
-7.64% |
-230.96% |
196.22% |
-42.43% |
17.04% |
-21.50% |
-221.17% |
280.07% |
-230.07% |
| NOPAT Q/Q Growth |
|
1.30% |
-53.57% |
-283.03% |
236.43% |
-45.36% |
24.23% |
-21.50% |
-184.82% |
357.25% |
-77.03% |
| Net Income Q/Q Growth |
|
1.59% |
-7.67% |
-232.15% |
195.02% |
-46.91% |
30.78% |
-19.75% |
-384.50% |
116.77% |
4.75% |
| EPS Q/Q Growth |
|
0.00% |
-14.29% |
-277.78% |
175.00% |
-54.17% |
54.55% |
-35.29% |
-481.82% |
109.52% |
0.00% |
| Operating Cash Flow Q/Q Growth |
|
1.55% |
0.38% |
-17.60% |
31.33% |
6.24% |
-19.33% |
-11.54% |
32.32% |
-17.24% |
13.14% |
| Free Cash Flow Firm Q/Q Growth |
|
-47.86% |
-85.57% |
-3.49% |
17.33% |
-27.83% |
52.36% |
-46.26% |
6.25% |
77.21% |
-124.77% |
| Invested Capital Q/Q Growth |
|
3.21% |
7.67% |
1.15% |
1.61% |
5.73% |
-0.76% |
4.09% |
0.15% |
-0.47% |
1.16% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
63.83% |
63.08% |
61.16% |
65.89% |
62.55% |
61.72% |
58.27% |
23.43% |
64.25% |
6.43% |
| EBIT Margin |
|
26.14% |
24.03% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-15.96% |
26.80% |
-97.49% |
| Profit (Net Income) Margin |
|
26.04% |
23.94% |
-29.82% |
26.93% |
14.49% |
18.92% |
15.10% |
-37.48% |
5.86% |
17.17% |
| Tax Burden Percent |
|
99.63% |
198.86% |
100.51% |
99.25% |
91.53% |
102.28% |
100.00% |
100.00% |
100.29% |
99.73% |
| Interest Burden Percent |
|
100.00% |
50.09% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
234.79% |
21.81% |
-17.66% |
| Effective Tax Rate |
|
0.37% |
0.00% |
0.00% |
0.75% |
5.79% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
|
2.92% |
1.31% |
-2.29% |
3.00% |
1.63% |
2.01% |
1.61% |
-1.23% |
3.03% |
1.70% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
2.92% |
2.15% |
-2.95% |
3.00% |
1.60% |
2.03% |
1.61% |
-3.00% |
1.60% |
1.70% |
| Return on Net Nonoperating Assets (RNNOA) |
|
1.76% |
1.39% |
-1.94% |
2.02% |
1.14% |
1.52% |
1.30% |
-2.47% |
1.40% |
1.53% |
| Return on Equity (ROE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
| Cash Return on Invested Capital (CROIC) |
|
-6.62% |
-12.68% |
-13.97% |
-12.29% |
-14.95% |
-6.68% |
-8.38% |
-8.78% |
-2.96% |
-5.07% |
| Operating Return on Assets (OROA) |
|
2.83% |
2.53% |
-3.18% |
2.94% |
1.68% |
1.95% |
1.57% |
-1.70% |
2.94% |
-9.32% |
| Return on Assets (ROA) |
|
2.82% |
2.52% |
-3.19% |
2.92% |
1.54% |
1.99% |
1.57% |
-3.99% |
0.64% |
1.64% |
| Return on Common Equity (ROCE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
| Return on Equity Simple (ROE_SIMPLE) |
|
4.78% |
0.00% |
1.94% |
2.09% |
1.61% |
0.00% |
3.58% |
0.26% |
-0.09% |
0.00% |
| Net Operating Profit after Tax (NOPAT) |
|
5.67 |
2.63 |
-4.82 |
6.58 |
3.59 |
4.47 |
3.67 |
-3.11 |
8.00 |
1.84 |
| NOPAT Margin |
|
26.04% |
12.04% |
-20.77% |
26.93% |
14.91% |
18.50% |
15.10% |
-11.17% |
26.80% |
17.22% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
-0.84% |
0.66% |
0.00% |
0.03% |
-0.03% |
0.00% |
1.77% |
1.43% |
0.00% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
|
73.86% |
75.97% |
129.67% |
72.86% |
84.17% |
81.50% |
84.90% |
76.43% |
73.20% |
197.49% |
| Earnings before Interest and Taxes (EBIT) |
|
5.69 |
5.26 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-4.44 |
8.00 |
-10 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
14 |
14 |
14 |
16 |
15 |
15 |
14 |
6.52 |
19 |
0.69 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
| Price to Tangible Book Value (P/TBV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
| Price to Revenue (P/Rev) |
|
8.58 |
9.18 |
9.74 |
8.69 |
7.80 |
6.96 |
7.15 |
6.30 |
4.80 |
5.86 |
| Price to Earnings (P/E) |
|
31.64 |
35.82 |
89.79 |
75.12 |
87.07 |
86.48 |
37.65 |
451.84 |
0.00 |
0.00 |
| Dividend Yield |
|
6.08% |
5.66% |
5.37% |
5.92% |
6.53% |
7.38% |
7.14% |
8.00% |
10.11% |
9.60% |
| Earnings Yield |
|
3.16% |
2.79% |
1.11% |
1.33% |
1.15% |
1.16% |
2.66% |
0.22% |
0.00% |
0.00% |
| Enterprise Value to Invested Capital (EV/IC) |
|
1.31 |
1.33 |
1.42 |
1.33 |
1.22 |
1.16 |
1.18 |
1.14 |
1.03 |
1.06 |
| Enterprise Value to Revenue (EV/Rev) |
|
12.22 |
13.15 |
13.83 |
12.69 |
12.03 |
11.12 |
11.66 |
10.85 |
9.24 |
11.06 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
18.62 |
20.44 |
21.87 |
19.97 |
19.04 |
17.69 |
23.30 |
21.81 |
18.14 |
25.27 |
| Enterprise Value to EBIT (EV/EBIT) |
|
45.38 |
51.20 |
126.21 |
108.31 |
127.79 |
132.88 |
60.53 |
58.53 |
43.01 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
51.25 |
51.30 |
173.27 |
143.55 |
182.00 |
138.15 |
61.42 |
672.23 |
0.00 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
17.24 |
18.74 |
20.83 |
19.26 |
18.02 |
17.36 |
18.43 |
17.74 |
17.04 |
17.39 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
| Long-Term Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
| Financial Leverage |
|
0.60 |
0.65 |
0.66 |
0.67 |
0.71 |
0.75 |
0.80 |
0.82 |
0.88 |
0.90 |
| Leverage Ratio |
|
1.66 |
1.70 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
1.88 |
1.94 |
1.96 |
| Compound Leverage Factor |
|
1.66 |
0.85 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
4.41 |
0.42 |
-0.35 |
| Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
|
60.62% |
58.46% |
57.53% |
57.85% |
56.56% |
56.00% |
53.63% |
52.10% |
50.18% |
49.48% |
| Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
| Net Debt to EBITDA |
|
5.55 |
6.17 |
6.46 |
6.28 |
6.70 |
6.62 |
9.02 |
9.15 |
8.71 |
11.88 |
| Long-Term Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
| Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
| Net Debt to NOPAT |
|
15.27 |
15.48 |
51.19 |
45.17 |
64.03 |
51.68 |
23.77 |
282.03 |
-1,491.54 |
-216.27 |
| Long-Term Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
-64 |
-119 |
-124 |
-102 |
-131 |
-62 |
-91 |
-85 |
-19 |
-44 |
| Operating Cash Flow to CapEx |
|
503.31% |
418.98% |
306.86% |
445.17% |
495.30% |
190.05% |
247.27% |
232.83% |
192.69% |
303.51% |
| Free Cash Flow to Firm to Interest Expense |
|
-21.26 |
-34.48 |
-30.97 |
-24.68 |
-28.15 |
-12.40 |
-17.92 |
0.00 |
0.00 |
-2.34 |
| Operating Cash Flow to Interest Expense |
|
5.07 |
4.45 |
3.18 |
4.03 |
3.82 |
2.85 |
2.50 |
0.00 |
0.00 |
0.84 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
4.06 |
3.39 |
2.14 |
3.12 |
3.05 |
1.35 |
1.49 |
0.00 |
0.00 |
0.56 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
0.11 |
0.11 |
0.10 |
| Fixed Asset Turnover |
|
0.08 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.11 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
| Invested Capital Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
| Increase / (Decrease) in Invested Capital |
|
70 |
122 |
119 |
109 |
134 |
67 |
94 |
82 |
27 |
45 |
| Enterprise Value (EV) |
|
1,032 |
1,130 |
1,220 |
1,158 |
1,126 |
1,066 |
1,130 |
1,089 |
980 |
1,024 |
| Market Capitalization |
|
724 |
789 |
860 |
794 |
730 |
667 |
693 |
632 |
509 |
543 |
| Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
| Tangible Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
| Total Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
| Total Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
| Total Long-Term Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
| Net Debt |
|
307 |
341 |
360 |
364 |
396 |
399 |
437 |
457 |
471 |
482 |
| Capital Expenditures (CapEx) |
|
3.05 |
3.68 |
4.14 |
3.75 |
3.58 |
7.52 |
5.11 |
7.19 |
7.19 |
5.16 |
| Net Nonoperating Expense (NNE) |
|
0.00 |
-2.60 |
2.10 |
0.00 |
0.10 |
-0.10 |
0.00 |
7.32 |
6.25 |
0.01 |
| Net Nonoperating Obligations (NNO) |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
| Total Depreciation and Amortization (D&A) |
|
8.21 |
8.54 |
21 |
9.46 |
11 |
10 |
10 |
11 |
11 |
11 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
| Adjusted Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
5.67 |
1.84 |
-4.82 |
6.58 |
3.59 |
3.13 |
2.57 |
-3.01 |
5.60 |
1.29 |
| Normalized NOPAT Margin |
|
26.04% |
8.43% |
-20.77% |
26.93% |
14.91% |
12.95% |
10.57% |
-10.82% |
18.76% |
12.05% |
| Pre Tax Income Margin |
|
26.14% |
12.04% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-37.48% |
5.84% |
17.22% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
1.88 |
1.52 |
-1.73 |
1.60 |
0.82 |
0.89 |
0.72 |
0.00 |
0.00 |
-0.56 |
| NOPAT to Interest Expense |
|
1.87 |
0.76 |
-1.21 |
1.59 |
0.77 |
0.89 |
0.72 |
0.00 |
0.00 |
0.10 |
| EBIT Less CapEx to Interest Expense |
|
0.87 |
0.46 |
-2.76 |
0.70 |
0.05 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.83 |
| NOPAT Less CapEx to Interest Expense |
|
0.87 |
-0.30 |
-2.24 |
0.68 |
0.00 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.18 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
| Augmented Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
Key Financial Trends
Community Healthcare Trust (NYSE: CHCT) showed a much stronger finish to 2024, with quarterly net income recovering to $1.8 million in Q4 from a Q2 loss, while operating cash flow remained solid. However, the company still carries a meaningful debt load and interest burden, and its year-over-year results suggest a business that is stabilizing but not yet consistently improving.
- Q4 2024 earnings rebounded to $1.8 million, up from a loss of $10.4 million in Q2 2024, showing a clear recovery in profitability.
- Operating cash flow improved to $15.7 million in Q4 2024 from $13.8 million in Q3 2024 and $12.6 million in Q1 2024, indicating the core business continued to generate cash.
- Cash and equivalents increased to $4.0 million at the end of Q4 2024 from $2.8 million in Q3 2024, despite ongoing capital spending and dividends.
- Q4 2024 financing activity turned less dilutive than earlier in the year, with no common equity issuance in the quarter compared with share issuance in Q1 and Q2.
- Revenue mix remains heavily dependent on non-interest income, which totaled $29.3 million in Q4 2024, while net interest expense was still large at $18.6 million.
- Depreciation remains a major non-cash add-back at about $10.8 million per quarter, which is typical for a real estate-heavy business but keeps earnings and cash flow somewhat disconnected.
- Property-related expenses remain elevated, including insurance claims of $5.5 million in Q4 2024 and $5.9 million in Q3 2024.
- Long-term debt increased to $473.7 million at Q3 2024 from $401.2 million a year earlier, signaling higher leverage.
- Interest expense is a major drag, with cash interest paid of $6.1 million in Q4 2024 and $6.2 million in Q3 2024, much higher than prior-year levels.
- Q2 2024 was weak, with a net loss of $10.4 million and EPS of -$0.42, showing earnings can still swing sharply quarter to quarter.
Looking at the full period, CHCT’s business appears to have improved from the weaker middle of 2024. Q1 2024 was profitable, Q2 was sharply negative, and Q3 and Q4 returned to modest profits. That pattern suggests earnings volatility remains a key issue.
The balance sheet also shows a company that is still expanding its asset base. Total assets were roughly flat around $982 million at year-end 2024 versus $955 million in Q3 2023, but debt rose alongside that growth. Equity stayed positive and increased modestly, but retained earnings remained deeply negative, reflecting a long history of distributions and uneven profitability.
Bottom line: CHCT ended 2024 in better shape than it was in midyear, with healthier operating cash flow and a return to profits. Still, the high debt load, persistent interest expense, and quarter-to-quarter volatility remain important risks for investors to watch.
06/18/26 05:18 PM ETAI Generated. May Contain Errors.